Drug or treatment
Avelumab clinical trials
As of November 12, 2026, Find a Trial lists 9 clinical trials of Avelumab that are recruiting, at sites in 8 countries (most in France (4), South Korea (1), Lebanon (1)). By phase: Phase 2 (8), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 8Countries
Newest trials
All recruiting trials (9)
-
Cisplatin chemotherapy followed by maintenance avelumab for upper tract urothelial carcinoma
This trial will try maintenance avelumab after adjuvant cisplatin chemotherapy to see if it reduces recurrence in adults with high-risk, surgically removed upper tract urothelial carcinoma who are disease‑free after chemo.
-
Enfortumab vedotin plus avelumab as first-line treatment for advanced penile cancer
This trial tests whether combining enfortumab vedotin with avelumab helps men with advanced or metastatic penile squamous cell carcinoma as first-line treatment.
-
Comparing 3 vs 6 cycles of chemotherapy followed by avelumab for advanced bladder cancer
This study is testing whether giving 3 or 6 cycles of chemotherapy followed by avelumab can improve the quality of life for people with advanced bladder cancer.
-
Combining chemotherapy with cetuximab and avelumab for advanced head and neck cancer
This study is testing a new treatment plan that combines chemotherapy with two medications, cetuximab and avelumab, to see if it helps people with advanced head and neck cancer live longer without their disease getting worse.
-
Tetra-modality bladder-preservation approach in muscle-invasive bladder cancer
This trial tests whether adding the immunotherapy drug avelumab to tumor removal, chemotherapy, and radiation can help people with muscle-invasive bladder cancer keep their bladder.
-
Combining Avelumab with Standard Chemotherapy for Advanced Head and Neck Cancer
This study is testing if adding avelumab to standard chemotherapy can help people with advanced head and neck cancer live longer and feel better.
-
Combining Lurbinectedin and Avelumab for Small Cell Carcinoma of the Bladder
This study is testing if a combination of two drugs, lurbinectedin and avelumab, can help people with small cell carcinoma of the bladder and similar tumors feel better when their cancer has come back or spread.
-
Combination of Talazoparib and Avelumab for Urothelial Carcinoma Maintenance Therapy
This study is testing if a combination of two drugs, Talazoparib and Avelumab, can help people with advanced bladder cancer stay healthy longer after their initial chemotherapy.
-
Using Avelumab and Methotrexate to Treat Low-risk Gestational Trophoblastic Neoplasias
This study is testing if combining avelumab with methotrexate can help women with low-risk gestational trophoblastic neoplasias feel better and have fewer side effects than standard chemotherapy.
Quick answers
How many clinical trials of Avelumab are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in France (4 trials), South Korea (1 trial), Lebanon (1 trial), Germany (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 8, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.